|Year : 2017 | Volume
| Issue : 2 | Page : 78-84
Value of oxytocin in modifying metabolic changes and atherosclerosis in rat model of diet-induced obesity
Maher N Ibrahim, Mohammed A Alghannam, Randa S Gomaa, Nourelhuda A Elsayed
Physiology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
|Date of Submission||21-Jun-2017|
|Date of Acceptance||17-Jul-2017|
|Date of Web Publication||21-Nov-2017|
Randa S Gomaa
Faculty of Medicine, Zagazig University, 44519
Source of Support: None, Conflict of Interest: None
Background Oxytocin (OT) has effects on uterine contraction and milk ejection, but growing evidence suggests that OT plays an important role in the regulation of energy homeostasis and development of obesity.
Objective The aim of this study was to investigate the effect of OT in modifying metabolic changes and atherosclerosis in diet-induced obesity rat model and its possible mechanisms.
Materials and methods A total of 30 male rats and 60 female adult albino rats were divided into three main groups: male, female, and the ovariectomized group. Each group was subdivided into three equal groups: control, high-fat diet (HFD) fed, and HFD-OT-treated groups. Body mass index, body weight gain and mean arterial blood pressure were measured. Serum cholesterol, triglycerides, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, nitric oxide, reduced glutathione, malondialdehyde, C-reactive protein, insulin, and glucose were estimated, and atherogenic index was calculated. Aortic artery histopathology was studied.
Results In all groups, OT treatment to HFD-fed rats decreased body mass index and weight gain and improved hyperlipidemia, high glucose, low insulin levels, and elevated mean arterial blood pressure caused by HFD. It showed antioxidative stress activity as indicated by decreased C-reactive protein and malondialdehyde (MDA) and elevated nitric oxide and glutathione levels. OT treatment reveled anti-inflammatory action as indicated by aortic histopathology.
Conclusion OT administration to HFD-fed rats reduced body mass index and weight gain and improved metabolic changes associated with lipid profile, glucose tolerance, and blood pressure. In addition, it dramatically ameliorated the aortic atherosclerotic changes. This effect is due to its antioxidative stress activity and anti-inflammatory action, and this effect was more prominent in female and ovariectomized female rats. Further studies are recommended for more evaluation of other mechanisms that explain the metabolic action of OT and to clarify the difference in its action on sex and other species of experimental animals.
Keywords: atherosclerosis, hyperlipidemia, inflammation, oxytocin
|How to cite this article:|
Ibrahim MN, Alghannam MA, Gomaa RS, Elsayed NA. Value of oxytocin in modifying metabolic changes and atherosclerosis in rat model of diet-induced obesity. Al-Azhar Assiut Med J 2017;15:78-84
|How to cite this URL:|
Ibrahim MN, Alghannam MA, Gomaa RS, Elsayed NA. Value of oxytocin in modifying metabolic changes and atherosclerosis in rat model of diet-induced obesity. Al-Azhar Assiut Med J [serial online] 2017 [cited 2019 Jan 23];15:78-84. Available from: http://www.azmj.eg.net/text.asp?2017/15/2/78/218854
| Introduction|| |
Although the nonapeptide oxytocin (OT) is well known for its peripheral effects on uterine contraction during parturition and milk ejection during lactation , growing evidence suggests that OT plays an important role in the regulation of energy homeostasis  plus other paraventricular nucleus functions such as regulation of food intake, responses to stress, modulation of metabolic rate, thermoregulation, and modulation of sympathetic nerve activity and cardiovascular (CV) function ,.
Obesity has been thought to be growing problem in the world even in young ages. Although the most severe complications of obesity do not manifest until later in life, CV health consequences may already be evident at a young age . Obesity is associated with increased rates of hypertension, hyperlipidemia, type 2 diabetes mellitus, and early development of atherosclerotic lesions. The effects of obesity and overweight affect the CV system in the form of arrhythmias, peripheral vascular disease, stroke, sudden death, coronary heart disease, hypertension, congestive heart failure, and most predominantly atherosclerosis .
Menopause, characterized by a reduction in the circulating levels of the ovarian hormones progesterone and estrogen, is an important risk factor for CV diseases. More specifically, ovarian hormone deprivation has been shown to lead to hypertension, abnormal plasma lipids, endothelial dysfunction, elevated oxidative stress, autonomic imbalance, and baroreflex impairment, which collectively result in high morbidity and mortality .
Numerous subsequent studies supported that adipose tissue is producing a variety of proinflammatory mediators such as tumor necrosis factor-α (TNF-α), interleukins (IL)-1, IL-6, and monocyte chemotactic protein 1 factors traditionally associated with inflammatory cells . Similar to TNF-α the production of these ‘adipokines’ is a function of the health of the tissue and under conditions of nutrient excess, obesity, and progressive insulin resistance, there is substantial proinflammatory adipokine production .
On the basis of these observations, the aim of the current study was to investigate the effect of OT in modifying changes associated with lipid profile, glucose tolerance, and blood pressure and the susceptibility to develop atherosclerosis in diet-induced obesity (DIO) rat model and to study the possible mechanisms of this effect.
| Materials and methods|| |
A total of 30 male rats and 60 female adult albino rats of 12–15 weeks old weighing 180–220 g were provided from The Animal House Faculty of Veterinary Medicine, Zagazig University. They were maintained for a week for acclimatization under conditions of controlled temperature (24–26°C), humidity (50–60%), and 12 h light–dark cycle. They were fed a standard diet with free access to water . All experimental procedures were carried out in accordance with research protocols established by the Institutional Review Board (IRB) Committee, Faculty of Medicine, Zagazig University, Egypt.
The animals were divided into three main groups of 30 rats each:
- Group I: the male group.
- Group II: the female group.
- Group III: the ovariectomized female group.
All groups were subdivided into three equal subgroups (each contained 10 rats):
- Groups Ia, IIa, and IIIa (the control groups) were fed normal diet.
- Groups Ib, IIb, and IIIb) [the high-fat diet (HFD)-fed groups] were fed HFD comprising 16.45% protein, 25.6% carbohydrate, and 58.0% fat in the form of cotton seed oil added to the laboratory chow diet for 12 weeks .
- Groups Ic, IIc, and IIIc) (the OT-treated groups) were fed HFD as HFD groups and on the 10th week of the experiment they were treated with OT at a dose of 0.01 ml/100 g/day for 14 days . While the control and HFD-fed groups were injected with i.m saline at a dose 0.01 ml/100 gm/day on the 10th week of the experiment for 14 days.
Ovariectomy technique was performed after acclimatization according to Veronique et al. . Body weight gain was measure using a sensitive digital scale by calculating the difference between body weights at the start and at the end of the experiment. Weight gain was calculated as percentage change in the initial body weight. Body mass index (BMI) was calculated for each animal at the end of the experiment by the equation: BMI (gm/cm2) = body weight/length2 (nose to anus length) this index can be used as an indicator of obesity where the cutoff value of obesity BMI is more than 0.68 gm/cm2 .
Mean arterial blood pressure (MABP) was measured at the end of the experiment using tail-cuff device (Narco Biosystem Inc., Huston, Texas, USA) after the animals had been warmed for 30 min in a metabolic chamber maintained at 300 by 30°C. All measurements were made at the same time of the day. The mean values of MABP obtained from three consecutive measurements were recorded as the pressure values for each rat.
After that, the rats were killed after 12 h of fasting under anesthesia (chloral hydrate inhalation). Blood samples were obtained by means of exsanguination at the time of scarification, collected, and allowed to clot for 2 h at room temperature before centrifugation. The sera were stored at −20°C until analysis. Repeated freezing and thawing was avoided. Thereafter, the thoracic aorta was rapidly removed and fixed in 10% neutral-buffered formalin. Sections of 5 μm were stained with hematoxylin and eosin and then were examined with light microscopy for histopathology.
The sera were examined for the following: levels of insulin using enzyme-linked immunosorbent assay (ELISA) kits (Bio Basic INC, USA) according to the method of Temple et al. ; levels of glucose using ELISA kits according to the method of Tietz ; levels of total cholesterol (TC) using colorimetric method according to the method of Allain et al. ; and triglyceride (TG) levels using enzymatic assay according to the method of Wahlefeld . Determination of high-density lipoprotein-cholesterol (HDL-C) was carried out using enzymatic assay according to the method of Finely . Low-density lipoprotein-cholesterol (LDL-C) was calculated using Friedewald’s formula : LDL-C=[TC − (HDL-cholesterol − TG)/5]. The atherogenic index (AI) was calculated from the following formula :
Estimation of serum C-reactive protein (CRP) level was carried out using immune enzymatic assay technique described by Ridker et al. . Nitric oxide (NO) was determined using Rat ELISA kits for evaluation of its oxidant products, nitrates and nitrites, using Griess reaction . Plasma levels of malondialdehyde (MDA) were determined using Rat ELISA kits as described by Ohkawa . Reduced glutathione (GSH) levels were determined using spectrophotometry according to the method of Jayatilleke and Shaw .
The results were presented as mean±SD. Statistical analysis was performed using the statistical package for the social sciences, version 19.0 (SPSS Inc., Chicago, Illinois, USA). Repeated measures of analysis of variance was applied followed by least significance differences for multiple comparisons. Levels of significance (P) were considered to be statistically significant when P value less than 0.05 .
| Results|| |
Effect of high-fat diet and treatment with oxytocin on BMI, weight gain and lipid profile
There was an increase in BMI and weight gain with increase in serum levels of TC, TG, LDL-C, and AI with decrease in HDL-C serum level in all HFD-fed groups (groups Ib, IIb, and IIIb) in comparison with their controls (groups Ia, IIa, and IIIa). OT-treated groups (groups Ic, IIc, and IIIc) showed a decrease in weight gain with significantly decreased serum levels of TC, TG, LDL-C, and AI with increase in HDL-C serum level in comparison with HFD-fed groups ([Table 1],[Table 2],[Table 3]).
|Table 3 Comparison of all studied parameters in ovariectomized female groups|
Click here to view
Effect of high-fat diet and treatment with oxytocin on glucose metabolism
There was an increase in serum glucose with decrease in serum insulin levels in all HFD-fed groups (groups Ib, IIb, and IIIb) in comparison with their controls (groups Ia, IIa, and IIIa). OT-treated groups (groups Ic, IIc, and IIIc) showed a decrease in serum glucose with increase in serum insulin levels in comparison with HFD-fed groups ([Table 1],[Table 2],[Table 3]).
Effect of high-fat diet and treatment with oxytocin on mean arterial blood pressure
MABP results revealed a significant increase in it in all HFD groups (groups Ib, IIb, and IIIb) in comparison with their controls (groups Ia, IIa, and IIIa). OT-treated groups (groups Ic, IIc, and IIIc) showed a significant decrease in MABP in comparison with HFD-fed groups ([Table 1],[Table 2],[Table 3]).
Effect of high-fat diet and treatment with oxytocin on oxidative stress markers
There was a significant increase in CRP and MAD serum levels with a significant decrease in NO and GSH serum levels in all HFD-fed groups (groups Ib, IIb, and IIIb) in comparison with their controls (groups Ia, IIa, and IIIa). OT-treated groups (groups Ic, IIc, and IIIc) showed a significant decrease in CRP and MDA serum levels, whereas a significant increase in NO and GSH serum levels in comparison with HFD-fed groups ([Table 1],[Table 2],[Table 3]).
Groups Ia, IIa, and IIIa
The wall of the aorta in the rats showed normal architecture with normal three layers: the tunica intima with characteristic endothelial layer and delicate subendothelial connective tissue; the tunica media, which is formed of several layers of smooth muscle fibers intermingled with a large amount of elastic fibers; and the tunica adventia, which is formed of loose connective tissues rich in elastic fibers ([Figure 1]-I).
|Figure 1 Photograph of transverse sections of the aorta. (Slide 1-I): Transverse section of the aorta of control groups (Groups Ia, IIa & IIIa) showing normal histological structures of intima, media and adventitia. (Slide 1-Ib): Transverse section of the aorta of group Ib shows focal areas of intimal thickening (A) with atheromatous cap formation and intimal protrusion into lumen (B). (Slide1- IIb): Transverse section of the aorta of group IIb shows focal areas of intimal thickening (A) and atheromatous cap formation with intimal protrusion into lumen (B) with focal ulceration of intimal lining (C) with focal atrophy of media (D). (Slide1- IIIb): Transverse section of the aorta of group IIIb shows focal areas of intimal thickening with sub-intimal proliferation and migration of smooth muscle cells associated with extra cellular matrix deposition (A) and intimal protrusion into lumen (B) with focal ulceration; by higher power (slide 1-IIIbH): there is intimal proliferation and subintimal migration of smooth muscle cells, macrophages and mononuclear cells infiltration, formation of foam cells with extracellular needle-like crystal of fat. (Slides1- Ic, IIc & IIIc): Transverse section of the aorta of Groups Ic, IIc & IIIc show The thickness of the walls of the aortas and histological structure of these groups similar to those of the control groups except presence of intimal protrusion into lumen (B) in all treated groups and remnants of intimal damage in the form of residual ulceration (C) in group IIIC (slid1- IIIC).|
Click here to view
Groups Ib, IIb, and IIIb
The wall of the aorta showed atherogenic changes in the form of focal areas of intimal thickening with atheromatous cap formation and intimal protrusion into lumen in group Ib ([Figure 1]-Ib). In group IIb, in addition to these changes there was focal ulceration of intimal lining and focal atrophy of media ([Figure 1]-IIb). In group IIIb, in addition to the changes that appeared group IIb, except for focal atrophy of the media, there was subintimal proliferation and migration of smooth muscle cells associated with macrophages and mononuclear cells infiltration, formation of foam cells, and extracellular needle-like crystal of fat ([Figure 1]-IIIb).
Groups Ic, IIc, and IIIc
The thickness of the wall of the aorta and histological structure of these groups were similar to those of the control groups except for the presence of except presence of intimal protrusion into lumen (B) in all treated groups and remnants of intimal damage in the form of residual ulceration (C) in group IIIC (slid IIIC) ([Figure 1]-Ic, [Figure 1]IIc and [Figure 1]IIIc).
| Discussion|| |
The results of the current study revealed that OT treatment to HFD-fed rats decreased BMI and weight gain and improved hyperlipidemia, high serum glucose level, low serum insulin level, and the elevated MABP caused by HFD in male, female, and ovariectomized female white albino rats.
These results are in accordance with Deblon et al.  who reported that chronic subcutaneous infusion of OT to DIO rats, OT reduces body weight at doses that not reducing food intake. They also reported that chronic central OT infusion dose-dependently restricted weight gain and increased adipose tissue lipolysis in rats with HFD-induced obesity and decreased plasma TG level. These changes were accompanied by increases in the epididymal adipose tissue expression of enzymes involved in lipolysis and fatty acid β-oxidation, indicating that OT negatively modulates adipogenesis. They found that chronic central and peripheral OT administration improved glucose tolerance and significantly reduced insulin secretion during the glucose tolerance test and indicated increased insulin sensitivity, which is unrelated to the decrease in food intake.
In addition, Zhang et al.  reported that, in mice with HFD-induced obesity, acute treatment with OT reversed insulin resistance and glucose intolerance before reduction of obesity, thus dissecting the OT’s glucoregulatory pathways from its long-term effect on body weight.
In another research, Blevins et al.  found that in male DIO rhesus monkeys maintained on chow and a daily 15% fructose-sweetened beverage, chronic administration of OT for 4 weeks reduced BW and food intake, increased energy expenditure with elevations of free fatty acids and glycerol and reductions in TG suggesting increased lipolysis, and decreases the plasma glucose level, whereas increases insulin plasma level, especially with the higher dose of OT.
In addition, Lawson et al.  reported that there was a trend toward reduction in TG level and reduced average insulin levels, but there was no effect on glucose levels following a single dose of intranasal OT in fasting healthy men; this indicated that OT may improve insulin sensitivity independently of its effects on weight. However, Ott et al.  showed that intranasal OT reduced postprandial glucose but not insulin levels in healthy men.
In contrast, Ahmed and Elosaily  found that male albino rats that received OT treatment for 10 weeks showed a nonsignificant change in the plasma levels of TC and TGs LDL-C and HDL-C but decreased mean systolic blood pressure values nearly similar to those of the control group.
In addition, Altirriba et al.  found that in mice model of obesity, hyperinsulinemia, and diabetes treated for 2 weeks with different doses of OT, surprisingly, treatment of mice model was accompanied by worsened glucose tolerance likely due to increased corticosterone levels and stimulation of hepatic gluconeogenesis. These effects were independent of food intake, but the treatment increased basal insulinemia in that model.
Adding to Szeto et al. , who reported that chronic OT treatment in an animal model, the Watanabe heritable hyperlipidemic rabbit did not differentially affect serum cholesterol, TGs, and free fatty acids but decreased serum level of glucose and increased serum level of insulin and showed no differences in blood pressure or heart rate compared with their controls.
The present results revealed that OT treatment to HFD-fed rats showed antioxidative stress activity that developed by HFD in male, female, and ovariectomized female rats as indicated by decreased levels of CRP and MAD and elevated levels of NO and GSH. At the same time, OT treatment reveled anti-inflammatory action, which was more prominent in female and ovariectomized female rats as indicated by aortic histopathological examination.
These findings are in agreement with the research, which reported that OT administration led to an increase in the plasma levels of NO and GSH and decreased the plasma levels of MDA and CRP to normal and confirm these findings by aortic histopathology, mostly because OT administration prevented both lipid peroxidation and GSH depletion. Thus, it supports the maintenance of cellular integrity indicating that the protective effect of OT involves the maintenance of antioxidant capacity in protecting the tissues against oxidative stress .
Moreover, Oliveira-Pelegrin et al.  demonstrated that OT administration in male Wistar rats led to the release of NO and affected cytokine production by macrophages and abolished the sepsis-induced increase in TNF-α. It has also been reported that OT decreased IL-6 secretion from macrophages and endothelial cells in a dose-dependent manner, and attenuated superoxide production in aortic endothelial and smooth muscle cells, monocytes, and macrophages.In addition, Nation et al.  found that in-vivo chronic OT infusion in Apo E knockout mice, which is more liable to develop atherosclerosis, attenuated aortic atherosclerotic changes and plasma CRP and inhibited the secretion of the proinflammatory cytokine IL-6 in visceral adipose tissue.
Szeto et al.  reported in their study that chronic OT treatment slows the progression of atherosclerosis in the animal model described before. Reduced atherosclerosis was associated with decreased systemic inflammation, as reflected by circulating CRP, but without affecting other traditional risks factors for atherosclerosis or stress hormones supporting the argument that the OT-related attenuation of atherosclerosis may be through the suppression of local vascular and systemic inflammation.
In contrast, other researchers suggested that OT has stimulator effect on oxidative stress reaction as Schneid-Kofman , who demonstrated that, in pregnant women who received OT for augmentation of labor, there were lower GSH levels in comparison with women who did not receive OT, which indicated an oxidative stress reaction.
In addition, Iqbal et al.  reported that in 20 buffaloes, which were injected with OT before each milking (morning and evening) for milk let down and then they were assessed for oxidative stress biomarkers; they showed elevated total oxidant status, total homocysteine, and ceruloplasmin oxidase activity in lactating buffaloes injected with OT as compared with the control group. However, serum levels of total antioxidant capacity and paraoxonase-1 were significantly lower in the treated group.
| Conclusion|| |
OT administration to HFD rats reduced BMI and weight gain and improved MABP and the metabolic changes associated with lipid profile, glucose tolerance, and blood pressure. In addition, it dramatically ameliorated the aortic atherosclerotic changes. This effect is due to its antioxidative stress activity and anti-inflammatory action, and this effect was more prominent in female and ovariectomized female rats. Further studies are recommended for more evaluation of other mechanisms that explain the metabolic action of OT and to clarify the difference in action of OT on sex and other species of experimental animals.
The histopathological assessment in the current study was done by Prof. Mohammad Ahmad Fouad Hussin Professor of Pathology, faculty of Medicine, Zagazig University.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001; 81:629–683.
Morton GJ, Thatcher BS, Reidelberger RD, Ogimoto K, Wolden-Hanson T, Baskin DG, Blevins JE. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab 2012; 302:134–144.
Ding L, Zhang LL, Gao R, Chen D, Wang JJ, Gao XY, Zhu GQ. Superoxide anions in paraventricular nucleus modulate adipose afferent reflex and sympathetic activity in rats. PLoS One 2013; 8:e83771.
Xiong XQ, Chen WW, Zhu GQ. Adipose afferent reflex: sympathetic activation and obesity hypertension. Acta Physiol 2014; 210:468–478.
Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, Rönnemaa T. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003; 290:2277–2283.
Wilborn C, Beckham J, Campbell B, Harvey T, Galbreath M, La Bounty P, Kreider R. Obesity: prevalence, theories, medical consequences, management, and research directions. J Int Soc Sports Nutr 2005; 2:4–31.
Flues K, Paulini J, Brito S, Sanches IC, Consolim-Colombo F, Irigoyen M-C, De Angelis K. Exercise training associated with estrogen therapy induced cardiovascular benefits after ovarian hormones deprivation. Maturitas 2010; 65:267–271.
Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 2005; 288:2031–2041.
Christiansen T, Richelsen B, Bruun J. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes 2005; 29:146–150.
Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buléon M, Carpéné C. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 2008; 8:437–445.
Cha MC, Chou CJ, Boozer CN. High-fat diet feeding reduces the diurnal variation of plasma leptin concentration in rats. Metabolism 2000; 49:503–507.
Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon A, Bussier AL, Petrosino S, Foti M. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One 2011; 6:e25565.
Veronique G, Nichala SA, Lavahan J, Paul H. Alpha adrenergic responses of Bl. V. of rabbits after ovariectomy and administration of 17 B-estradiol. J Pharmacol Exp Ther 1987; 240:66.
Temple R, Clark P, Hales C. Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabet Med 1992; 9:503–512.
Tietz NW. Clinical guide to laboratory tests. USA: WB Saunders Co.; 1995.
Allian CC, Pooom LS, Chan SG, Richmond W, Fu PC. Quantitative enzymatic colorimetric determination of total HDL, cholesterol in serum or plasma. Clinc Chem 1974; 20;470–475.
Wahlefeld AW. Ouantitative enzymatic colorimetric determination of triglycerides in serum or plasma. In: Bergmeyer HU. Methods of enzymatic analysis. New York: Academic Press 1974. 5 1831–1835.
Finely PR. Enzymatic determination of HDL-C. Clin Chem 1978; 24:931–934.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of concentrations of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499–502.
Dobiásová M. Atherogenic index of plasma [log (triglycerides/HDL-cholesterol)]: theoretical and practical implications. J Clin Chem 2004; 50:1113–1115.
Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998; 97:2007–2011.
Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141:2407–2412
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95:351–358.
Jayatilleke E, Shaw S. A high-performance liquid chromatographic assay for reduced and oxidized glutathione in biological samples. Anal Biochem 1993; 214:452–457.
Knapp GR, Miller MC. Tests of statistical significance: regression and correlation. In: Clinical epidemiology and biostatistics. 1st ed. Baltimore, Maryland: Williams & Wilkins, Indiana University; 1992:255–274.
Zhang H, Wu C, Chen Q, Chen X, Xu Z, Wu J, Cai D. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS One 2013; 8:e61477.
Blevins JE, Graham JL, Morton GJ, Bales KL, Schwartz MW, Baskin DG, Havel PJ. Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 2015; 308:431–438.
Lawson EA, Marengi DA, DeSanti RL, Holmes TM, Schoenfeld DA, Tolley CJ. Oxytocin reduces caloric intake in men. Obesity 2015; 23:950–956.
Ott V, Finlayson G, Lehnert H, Heitmann B, Heinrichs M, Born J, Hallschmid M. Oxytocin reduces reward-driven food intake in humans. Diabetes 2013; 62:3418–3425.
Ahmed MA, Elosaily GM. Role of oxytocin in deceleration of early atherosclerotic inflammatory processes in adult male rats. Int J Clin Exp Med 2011; 4:169–178.
Altirriba J, Poher AL, Caillon A, Arsenijevic D, Veyrat-Durebex C, Lyautey J, Rohner-Jeanrenaud F. Divergent effects of oxytocin treatment of obese diabetic mice on adiposity and diabetes. Endocrinology 2014; 155:4189–4201.
Szeto A, Rossetti MA, Mendez AJ, Noller CM, Herderick EE, Gonzales JA, McCabe PM. Oxytocin administration attenuates atherosclerosis and inflammation in Watanabe Heritable Hyperlipidemic rabbits. Psychoneuroendocrinology 2013; 38:685–693.
Oliveira-Pelegrin GR, Saia RS, Carnio EC, Rocha MJA. Oxytocin affects nitric oxide and cytokine production by sepsis-sensitized macrophages. Neuroimmunomodulation 2013; 20:65–71.
Nation DA, Szeto A, Mendez AJ, Brooks LG, Zaias J, Herderick EE, McCabe PM. Oxytocin attenuates atherosclerosis and adipose tissue inflammation in socially isolated ApoE−/−
mice. Psychosom Med 2010; 72:376.
Schneid-Kofman N, Silberstein T, Saphier O, Shai I, Tavor D, Burg A. Labor augmentation with oxytocin decreases glutathione level. Obstet Gynecol Int 2009; 2009:1–5.
Iqbal Z, Rahman ZU, Muhammad F, Khaliq T, Anwar H, Awais MM, Sadaf S. Oxytocin induced oxidative stress in lactating Bubalis bubalis
(Nili Ravi). BMC Vet Res 2013; 9:169–170.
[Table 1], [Table 2], [Table 3]